To view this email as a web page, click here.
 
Industry updates
 
Pipeline antibiotic omadacycline shows promise against MRSA and more
Phase 3 data for omadacycline has shown the pipeline drug effectively and safely treats the most frequently isolated bacterial pathogens associated with skin infections, including methicillin-resistant Staphylococcus aureus (MRSA)
Learn more.
ADVERTISEMENT
 
Tinea pedis treatment tests better than expected
A silicone-based gel with a nitric oxide platform has been found to be safe and efficacious for treating tinea pedis, according to the results of a Phase 2 trial.
Learn more.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
AZ - Integrated Dermatology
CO - Integrated Dermatology
CO - Leavitt Management Group
CT - Integrated Dermatology
CT - Integrated Dermatology
CT - Integrated Dermatology
CT - Integrated Dermatology
CT - Integrated Dermatology
FL - Eye Associates
District of Columbia - Integrated Dermatology
FL - Integrated Dermatology
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
GA - Leavitt Management Group
IL - Integrated Dermatology
IA - Integrated Dermatology
LA - Integrated Dermatology
MA - Integrated Dermatology
MA - Reliant Medical Group
MD - Integrated Dermatology
MD - Integrated Dermatology
MD - Integrated Dermatology
MI - Leavitt Management Group
MI - Leavitt Management Group
MI - Leavitt Management Group
National - Integrated Dermatology
National - Leavitt Management Group
National - US Dermatology Partners
NC - Integrated Dermatology
NY - Integrated Dermatology
NY - Integrated Dermatology
NY - Company Confidential
OH - Leavitt Management Group
OR - Cynthia Dreyer MD
PA - Leavitt Management Group
PA - Milton S Hershey Medical Center
TN - Integrated Dermatology
VA - Integrated Dermatology
VA - Integrated Dermatology
WI - Gundersen Lutheran Health System
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.